XML 40 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Vest Stock Option Activity (Details)
3 Months Ended
Mar. 31, 2023
USD ($)
$ / shares
shares
Share-Based Payment Arrangement, Employee [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Options Outstanding, Beginning of Period | shares 2,020,214
Weighted Average Exercise Price Outstanding, Beginning of Period | $ / shares $ 3.01
Weighted Average Remaining Contracted Term (years) Outstanding 8 years 10 months 9 days
Aggregate Intrinsic Value Outstanding, Beginning of Period | $
Number of Options, Granted | shares
Weighted Average Exercise Price, Granted | $ / shares
Aggregate Intrinsic Value, Granted | $
Number of Options, Forfeited | shares
Weighted Average Exercise Price, Forfeited | $ / shares
Aggregate Intrinsic Value, Forfeited | $
Number of Options, Expired | shares
Weighted Average Exercise Price, Expired | $ / shares
Aggregate Intrinsic Value, Expired | $
Number of Options Outstanding, Ending of Period | shares 2,020,214
Weighted Average Exercise Price Outstanding, End of Period | $ / shares $ 3.01
Weighted Average Remaining Contracted Term (years) Outstanding 8 years 6 months 18 days
Aggregate Intrinsic Value Outstanding, Ending of Period | $
Number of Options, Vested and Expected to Vest | shares 2,020,214
Weighted Average Exercise Price, Vested and Expected to Vest | $ / shares $ 3.01
Weighted Average Remaining Contracted Term (years), Vested and Expected to Vest 8 years 6 months 18 days
Aggregate Intrinsic Value, Vested and Expected to Vest | $
Number of Options Exercisable, End of Period | shares 1,752,888
Weighted Average Exercise Price Exercisable, Ending of Period | $ / shares $ 2.22
Weighted Average Remaining Contracted Term (years), Exercisable at End of Period 6 years 6 months 7 days
Aggregate Intrinsic Value, Exercisable at End of Period | $
Share-Based Payment Arrangement, Nonemployee [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Options Outstanding, Beginning of Period | shares 579,155
Weighted Average Exercise Price Outstanding, Beginning of Period | $ / shares $ 3.09
Weighted Average Remaining Contracted Term (years) Outstanding 7 years 11 months 4 days
Aggregate Intrinsic Value Outstanding, Beginning of Period | $
Number of Options, Granted | shares
Weighted Average Exercise Price, Granted | $ / shares
Aggregate Intrinsic Value, Granted | $
Number of Options, Forfeited | shares
Weighted Average Exercise Price, Forfeited | $ / shares
Number of Options Outstanding, Ending of Period | shares 579,155
Weighted Average Exercise Price Outstanding, End of Period | $ / shares $ 3.09
Weighted Average Remaining Contracted Term (years) Outstanding 8 years 4 months 9 days
Aggregate Intrinsic Value Outstanding, Ending of Period | $
Number of Options, Vested and Expected to Vest | shares 579,155
Weighted Average Exercise Price, Vested and Expected to Vest | $ / shares $ 3.09
Weighted Average Remaining Contracted Term (years), Vested and Expected to Vest 8 years 4 months 9 days
Aggregate Intrinsic Value, Vested and Expected to Vest | $
Number of Options Exercisable, End of Period | shares 474,988
Weighted Average Exercise Price Exercisable, Ending of Period | $ / shares $ 2.76
Weighted Average Remaining Contracted Term (years), Exercisable at End of Period 5 years 9 months
Aggregate Intrinsic Value, Exercisable at End of Period | $
Aggregate Intrinsic Value, Forfeited | $
Number of Options, Expired | shares
Weighted Average Exercise Price, Expired | $ / shares
Aggregate Intrinsic Value, Expired | $